← Leaderboards
Manisha Bahl
Massachusetts General Hospital
$1,302,726
Attributed
$1,302,726
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $261.3K · FY2019–23$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,302,726 · 1
By mechanism
K08$1,302,726 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Janie M Lee$2,641,472
- David A Boas$41,142,921
- Jessica Elizabeth Haberer$14,425,308
- Joel S. Weissman$10,911,478
- Giuliano Scarcelli$7,771,065
Others in their field
Other Emerging Leaders on “Deep Learning”
- Alan D. Palkowitz · Indiana University Indianapolis$17,630,798
- John E West · University Of Texas At Austin$15,799,827
- Leonard Freedman · Leidos Biomedical Research, Inc.$15,756,756
- Rene S. Kahn · Icahn School Of Medicine At Mount Sinai$13,240,338
- Neil King · University Of Washington$12,677,393
- Conor O'Neill · University Of California, San Francisco$10,429,562
Research focus
Deep LearningDevelopment PlansCostData ScienceAlgorithmsAssessment ToolConvolutional Neural NetworkCore BiopsyBreast Cancer DetectionComputer Vision SystemsCancer InvasivenessCancer Research ProjectCareerCareer DevelopmentAreaAdjuvant TherapyBiopsyClinical DataClinical ImplementationClinical PracticeBreast ImagingArtificial IntelligenceComputer ScienceDiagnosis
Grant awards (5)
Development and Clinical Implementation of an Artificial Intelligence Tool to Predict Risk of Upgrade of Ductal Carcinoma In Situ$261,328
K08 · FY2023 · CA · contact PI
Development and Clinical Implementation of an Artificial Intelligence Tool to Predict Risk of Upgrade of Ductal Carcinoma In Situ$261,328
K08 · FY2022 · CA · contact PI
Development and Clinical Implementation of an Artificial Intelligence Tool to Predict Risk of Upgrade of Ductal Carcinoma In Situ$260,112
K08 · FY2021 · CA · contact PI
Development and Clinical Implementation of an Artificial Intelligence Tool to Predict Risk of Upgrade of Ductal Carcinoma In Situ$259,979
K08 · FY2020 · CA · contact PI
Development and Clinical Implementation of an Artificial Intelligence Tool to Predict Risk of Upgrade of Ductal Carcinoma In Situ$259,979
K08 · FY2019 · CA · contact PI